ArticleJournal of contemporary brachytherapy2019

Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience.

Justin M Barnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.